files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
About US
Editors
Issues
Pages
Indexed in
136
Views
12
Downloads

Evaluation of Anti‐Mullerian Hormone Levels as a Diagnostic Marker of Polycystic Ovarian Syndrome: A Case‐Control Study in Reproductive Age Group Women

Supriya Wagh, Kailas Gadekar, Nadia Ali, Abhijit Ninghot and G. Santosh Varma
Page: 424-427 | Received 22 Nov 2023, Published online: 17 Dec 2023

Download Citation
https://doi.org/10.36478/10.59218/makrjms.2023.12.424.427

Full Text Reference XML File PDF File

Abstract

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age. Presently the diagnosis of PCOS is based on clinical and ultrasound findings. But these findings are subjective. So, there is a need of a biochemical marker to diagnose PCOS accurately which doesn’t get affected by the ovarian cycle. Anti‐mullerian hormone (AMH) secreted by ovaries. In this project we studied the Antimullerian hormone levels in PCOS patients. To estimate the Antimullerian hormone levels in women with PCOS and establish the role of AMH as a diagnostic marker of PCOS. It was a case control study carried out in tertiary care centre. AMH levels were estimated by electrochemiluminescence method. Mean AMH level in the cases was 36.47±9.29 pmol L and the controls was 20.07±4.63 pmol L the difference was statistically significant (p<0.001). As values of AMH correlate well with patients diagnosed with the Polycystic ovarian morphology in USG and other biochemical parameters in PCOS patients, it can be concluded that elevated AMH is indicative of PCOS and can be a diagnostic marker of PCOS. It can be used along with other biochemical parameters. Polycystic ovarian syndrome, anti‐mullerian hormone, diagnostic marker.

How to cite this article:

Supriya Wagh, Kailas Gadekar, Nadia Ali, Abhijit Ninghot and G. Santosh Varma. Evaluation of Anti‐Mullerian Hormone Levels as a Diagnostic Marker of Polycystic Ovarian Syndrome: A Case‐Control Study in Reproductive Age Group Women.
DOI: https://doi.org/10.36478/10.59218/makrjms.2023.12.424.427
URL: https://www.makhillpublications.co/view-article/1815-9346/10.59218/makrjms.2023.12.424.427